Join
Live feed
·
PRReleasevia Quantisnow
Eloxx Pharmaceuticals Inc. logo

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases

ByQuantisnow·Wall Street's wire, on your screen.
ELOX· Eloxx Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELOX (Eloxx Pharmaceuticals Inc.) and more on Quantisnow.